Hepatitis Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Hepatitis D Virus Therapy
Study results from Hippokration General Hospital, Department of Medicine provide new insights into hepatitis D virus therapy
July 9th, 2007
Fresh data on hepatitis D virus are presented in the report "Quantitative analysis of hepatitis D virus RNA and hepatitis B surface antigen serum levels in chronic delta hepatitis improves treatment monitoring. Treatment of chronic delta hepatitis is long and difficult and better monitoring is needed. In this study, hepatitis delta virus (HDV) RNA, hepatitis B surface antigen (HBsAg) and hepatitis B virus (HBV) DNA were retrospectively quantified in 53 patients with hepatitis B e antigen (HBeAg)-negative chronic hepatitis delta," scientists in Athens, Greece report. "Twenty-one had received 28 courses of 3-5 MU interferon-alpha2b (IFN-alpha2b) thrice weekly for a median...
Source: Hepatitis Weekly (2007-07-09)
|
